Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, New Jersey.
Cancer Res. 2022 Sep 16;82(18):3191-3197. doi: 10.1158/0008-5472.CAN-22-1535.
The BRCA1-PALB2-BRCA2 axis plays essential roles in the cellular response to DNA double-strand breaks (DSB), maintenance of genome integrity, and suppression of cancer development. Upon DNA damage, BRCA1 is recruited to DSBs, where it facilitates end resection and recruits PALB2 and its associated BRCA2 to load the central recombination enzyme RAD51 to initiate homologous recombination (HR) repair. In recent years, several BRCA1-independent mechanisms of PALB2 recruitment have also been reported. Collectively, these available data illustrate a series of hierarchical, context-dependent, and cooperating mechanisms of PALB2 recruitment that is critical for HR and therapy response either in the presence or absence of BRCA1. Here, we review these BRCA1-dependent and independent mechanisms and their importance in DSB repair, cancer development, and therapy. As BRCA1-mutant cancer cells regain HR function, for which PALB2 is generally required, and become resistant to targeted therapies, such as PARP inhibitors, targeting BRCA1-independent mechanisms of PALB2 recruitment represents a potential new avenue to improve treatment of BRCA1-mutant tumors.
BRCA1-PALB2-BRCA2 轴在细胞对 DNA 双链断裂 (DSB) 的反应、基因组完整性的维持和癌症发展的抑制中发挥着重要作用。在 DNA 损伤时,BRCA1 被招募到 DSB 处,在那里它促进末端切除,并招募 PALB2 及其相关的 BRCA2 加载中心重组酶 RAD51 以启动同源重组 (HR) 修复。近年来,也有报道了几种 BRCA1 非依赖性的 PALB2 募集机制。总之,这些现有数据说明了 PALB2 募集的一系列分层、依赖上下文和合作的机制,对于 HR 和治疗反应至关重要,无论是在存在 BRCA1 还是不存在 BRCA1 的情况下。在这里,我们回顾了这些 BRCA1 依赖性和非依赖性的机制及其在 DSB 修复、癌症发展和治疗中的重要性。由于 BRCA1 突变型癌细胞恢复了 HR 功能,而 PALB2 通常是必需的,并且对靶向治疗如 PARP 抑制剂产生耐药性,因此靶向 PALB2 募集的 BRCA1 非依赖性机制代表了改善 BRCA1 突变型肿瘤治疗的潜在新途径。